Compare Salem Erode Inv. with Similar Stocks
Stock DNA
Non Banking Financial Company (NBFC)
INR 37 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
0.06
-27.09%
2.16
Total Returns (Price + Dividend) 
Salem Erode Inv. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Salem Erode Investments Ltd is Rated Strong Sell
Salem Erode Investments Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 July 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 March 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Salem Erode Investments Ltd is Rated Strong Sell
Salem Erode Investments Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 July 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleAre Salem Erode Investments Ltd latest results good or bad?
Salem Erode Investments Ltd's latest financial results for Q2 FY26 indicate a challenging operational environment. The company reported a net loss of ₹1.20 crore, which reflects a significant decline compared to both the previous quarter and the same quarter last year, with losses widening by 21.21% QoQ and 41.18% YoY. Revenue also contracted, totaling ₹0.89 crore, down 18.35% from the prior quarter and 25.83% from the previous year, marking the weakest quarterly revenue performance in recent times. The operating margin deteriorated sharply to -57.30%, a decline from -23.85% in the prior quarter, highlighting ongoing difficulties in generating positive cash flow from core operations. Employee costs exceeded total revenue, contributing to an operating profit before depreciation, interest, and tax (PBDIT) of -₹0.51 crore, further emphasizing the company's unsustainable cost structure. Return on equity (ROE)...
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Feb-2026 | Source : BSENewspaper publication of unaudited standalone Financial results for the quarter ended December 31 2025
Results-Financial Results As On 31.12.2025
12-Feb-2026 | Source : BSEConsidered and approved the unaudited standalone financial results of the company for the quarter ended December 31 2025
Outcome Of The Board Meeting Held On Thursday February 12 2026 Of Salem Erode Investments Limited
12-Feb-2026 | Source : BSEConsidered and approved the unaudited standalone financial results of the company for the quarter ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Icl Fincorp Limited (75.0%)
None
14.47%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 1.23% vs -17.35% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 7.35% vs -466.67% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -7.91% vs -1.38% in Sep 2024
Growth in half year ended Sep 2025 is -1.86% vs -3,483.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -5.41% vs -6.33% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1.71% vs -1,070.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -5.87% vs 2.25% in Mar 2024
YoY Growth in year ended Mar 2025 is -159.34% vs -1,720.00% in Mar 2024






